372 completed, 102 terminated, 76 recruiting, 51 unknown. 701 Phase 1, 266 Phase 2.
Follow Cisplatin: new trials by email Literature Review of Cisplatin trials Research Report on Cisplatin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC Durvalumab 50 MG/1 ML Intravenous Solution, Etoposide Injection, Cisplatin - Extensive-stage Small-cell Lung Cancer | Phase 1 | Suspended | University of Maryland, Baltimore | 50 | 2027-01-30 | 2026-09-14 |
| Study of ISM5939 in Patients With Advanced and/or Metastatic Solid Tumors ISM5939, Cisplatin, Docetaxel - Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 | Not yet recruiting | InSilico Medicine Hong Kong Limited | 159 | 2026-12-30 | 2026-07-23 |
| Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma Biospecimen Collection, Cisplatin, Computed Tomography - Ann Arbor Stage II Mantle Cell Lymphoma, Ann Arbor Stage III Mantle Cell Lymphoma | Phase 1 | Not yet recruiting | National Cancer Institute (NCI) | 16 | 2026-12-30 | 2026-11-06 |
| Liposomal Irinotecan Plus Cisplatin in Patients With Advanced or Metastatic Solid Malignancies Liposomal Irinotecan Plus Cisplatin - Advanced Solid Malignancies | Phase 1 | Not yet recruiting | National Health Research Institutes, Taiwan | 44 | 2026-12-01 | 2026-11-02 |
| Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC) azacytidine, carboplatin, paclitaxel - Non-small Cell Lung Cancer (NSCLC), Carcinoma, Non-Small Cell Lung | Phase 1 / Phase 2 | Suspended | National Cancer Institute (NCI) | 60 | 2026-11-25 | 2026-11-20 |
| This is a Multicenter, Open-label, Phase I/II Study to Explore the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of GFH276 in Patients With Advanced NSCLC Harboring a RAS Mutation. GFH276, with or without Tislelizumab, Pemetrexed - RAS Mutation, Non-small Cell Lung Cancer (NSCLC) | Phase 1 / Phase 2 | Not yet recruiting | Genfleet Therapeutics (Shanghai) Inc. | 84 | 2026-11-01 | 2026-09-29 |
| A Multicenter, Prospective, Randomized, Open-label Phase Ib/II Study of Celecoxib Plus Pembrolizumab and Gemcitabine/Cisplatin Versus Pembrolizumab and Gemcitabine/Cisplatin in Patients With CK5/6-High Unresectable Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma Celecoxib + Pembrolizumab + Gemcitabine/Cisplatin, Pembrolizumab + Gemcitabine/Cisplatin - Intrahepatic Cholangiocarcinoma (Icc) | Phase 1 / Phase 2 | Not yet recruiting | Shanghai 6th People's Hospital | 112 | 2026-09-15 | 2026-08-28 |
| A Study of DXC006 With Immune Checkpoint Inhibitors or Platinum for Small Cell Lung Cancer. DXC006, Toripalimab, Carboplatin - Small Cell Lung Cancer | Phase 1 / Phase 2 | Recruiting | Hangzhou DAC Biotechnology Co., Ltd. | 200 | 2026-08-19 | 2026-09-24 |
| Phase 1B Trial of Intratumoral Cisplatin for Stage IV Lung Cancer cisplatin (cis-diamminedichloroplatinum(II) (CDDP)) - Lung Cancer Metastatic, Lung Cancer (NSCLC) | Phase 1 | Not yet recruiting | University of Vermont | 12 | 2026-07-01 | 2026-03-27 |
| Becotatug Vedotin Plus Cisplatin and Radiotherapy in LA-ESCC Becotatug Vedotin Combined with Cisplatin and Concurrent Radiotherapy - Esophageal Squamous Cell Carcinoma | Phase 1 | Not yet recruiting | Hebei Medical University Fourth Hospital | 12 | 2026-07-01 | 2026-07-10 |
| HSK41959 With Standard Therapy in Solid Tumors With MTAP Deletion HSK41959, Sintilimab, Pemetrexed + Cisplatin /Carboplatin - Non-Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma (mPDAC) | Phase 1 | Not yet recruiting | Haisco Pharmaceutical Group Co., Ltd. | 258 | 2026-07-01 | 2026-07-14 |
| AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer Biopsy Procedure, Cisplatin, Computed Tomography - Borderline Resectable Pancreatic Ductal Adenocarcinoma, Locally Advanced Cholangiocarcinoma | Phase 1 | Recruiting | Jonsson Comprehensive Cancer Center | 46 | 2026-05-29 | 2026-08-20 |
| QLS5132 Combination Therapy in Advanced Solid Tumors QLS5132; Bevacizumab, QLS5132; Platinum; Bevacizumab, QLS5132; Olaparib; Bevacizumab - Gastric Cancer (GC), Non-small Cell Lung Cancer (NSCLC) | Phase 1 / Phase 2 | Not yet recruiting | Qilu Pharmaceutical Co., Ltd. | 626 | 2026-04-01 | 2026-03-06 |
| Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer Emavusertib, Gemcitabine, Cisplatin - Metastatic Biliary Tract Cancer, Metastatic Biliary Tract Carcinoma | Phase 1 | Recruiting | Washington University School of Medicine | 48 | 2026-03-27 | 2026-04-03 |
| A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01 KRC-01, External Beam Radiation Therapy, cisplatin - Cervical Cancer | Phase 1 | Recruiting | Kortuc, Inc. | 70 | 2026-03-01 | 2026-04-08 |
| Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors Audiometric Test, Cisplatin, Computed Tomography - Hearing Loss, Metastatic Malignant Germ Cell Tumor | Phase 1 | Recruiting | City of Hope Medical Center | 44 | 2026-02-19 | 2026-04-17 |
| CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors CR-001, Paclitaxel, trifluridine and tipiracil - Locally Advanced / Metastatic Solid Tumors | Phase 1 / Phase 2 | Recruiting | Crescent Biopharma, Inc. | 540 | 2026-02-17 | 2026-11-13 |
| A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors 7MW3711, JS207, Cisplatin - Solid Tumor | Phase 1 / Phase 2 | Recruiting | Mabwell (Shanghai) Bioscience Co., Ltd. | 280 | 2026-02-11 | 2026-03-12 |
| Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer Adebrelimab, Gemcitabine + Cisplatin, Simvastatin 20mg - Advanced Biliary Tract Carcinoma | Phase 1 / Phase 2 | Recruiting | Tongji Hospital | 29 | 2026-01-30 | 2026-03-23 |
| Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors Daraxonrasib, Elironrasib, Zoldonrasib - Advanced Solid Tumors, Metastatic Solid Tumors | Phase 1 / Phase 2 | Recruiting | Revolution Medicines, Inc. | 370 | 2026-01-30 | 2026-11-04 |
Showing 20 of 701. Sign in to see all of them.
Carcinoma, Non-Small-Cell Lung (123) · Squamous Cell Carcinoma of Head and Neck (71) · Neoplasms (65) · Head and Neck Neoplasms (57) · Lung Neoplasms (54) · Stomach Neoplasms (39) · Uterine Cervical Neoplasms (38) · Neoplasm Metastasis (36) · Ovarian Neoplasms (35) · Small Cell Lung Carcinoma (32) · Colorectal Neoplasms (31) · Pancreatic Neoplasms (31) · Esophageal Neoplasms (28) · Urinary Bladder Neoplasms (26) · Cholangiocarcinoma (25)
National Cancer Institute (NCI) (50) · Memorial Sloan Kettering Cancer Center (31) · Eli Lilly and Company (23) · M.D. Anderson Cancer Center (16) · AstraZeneca (13) · Merck Sharp & Dohme LLC (13) · Pfizer (12) · Dana-Farber Cancer Institute (11) · Gynecologic Oncology Group (10) · City of Hope Medical Center (8) · Hoffmann-La Roche (8) · ImmunityBio, Inc. (8) · Roswell Park Cancer Institute (8) · GlaxoSmithKline (7) · University Health Network, Toronto (7)
United States (417) · China (101) · Spain (69) · France (63) · South Korea (54) · Canada (53) · Japan (49) · United Kingdom (48) · Italy (36) · Taiwan (35) · Australia (33) · Germany (32) · Belgium (29) · Netherlands (24) · Switzerland (14)
David H. Ilson, MD, PhD (5) · Corey J. Langer, MD (3) · Franco M. Muggia, MD (3) · Gary K. Schwartz, MD (3)
PMID 27246305, PMID 32571298, PMID 11181662, PMID 11573045, PMID 12607634, PMID 12717353, PMID 12771884, PMID 12885811, PMID 14666038, PMID 15033677, PMID 15131031, PMID 15328179, PMID 15863167, PMID 15890573, PMID 15958629, PMID 16149148, PMID 16170174, PMID 16368439, PMID 16394300, PMID 16889823, PMID 17084549, PMID 17140960, PMID 17336213, PMID 17398031, PMID 17410043, PMID 17482376, PMID 17538162, PMID 17538163, PMID 18299147, PMID 18628474, PMID 19010522, PMID 19100600, PMID 19139178, PMID 19219674, PMID 19221754, PMID 19228749, PMID 19509178, PMID 19636012, PMID 19738454, PMID 20022092, PMID 20605352, PMID 20818904, PMID 20923544, PMID 21205757, PMID 21220472, PMID 21257722, PMID 21307147, PMID 21412168, PMID 21892091, PMID 22010014
2023 (13), U10CA027469 (12), 2016 (11), 2015 (8), P30CA033572 (8), 2009 (7), 2017 (6), 2018 (6), U10CA180868 (6), P30CA015083 (5), 2008 (4), 2014 (4), 2025 (4), P30CA015704 (4), P30CA043703 (4)